A UK-based startup, CoMind, has secured more than $100 million in total funding to develop innovative brain monitoring and treatment technology that eliminates the need for drilling into a patient’s skull. This breakthrough approach aims to provide a less invasive alternative for neurological care, enhancing patient safety and treatment outcomes. The recent funding round highlights strong investor confidence in CoMind’s potential to transform brain health diagnostics and therapies.
Back
